CTOs on the Move

SelectCare of Texas

www.sctexas.com

 
SelectCare of Texas is a Houston, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million
  • www.sctexas.com
  • 4888 Loop Central Dr Ste 700
    Houston, TX USA 77081
  • Phone: 713.843.6725

Executives

Name Title Contact Details

Similar Companies

Stream Pickett

Stream Pickett is a Decatur, GA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Navicure

Navicure has chosen to focus exclusively on the needs of practices and institutions performing physician billing.

OneSpaWorld

Worldwide provider and innovator in the fields of wellness, beauty, rejuvenation and transformation across the globe at sea on cruise ships and on land.

Histogenics

Histogenics is a regenerative medicine company focused on developing and commercializing products in the musculoskeletal segment of the marketplace. Histogenics` regenerative medicine platform combines expertise in cell processing, scaffolding, tissue engineering, bioadhesives and growth factors to provide solutions that can be utilized individually or in concert to treat musculoskeletal-related conditions. Histogenics` first investigational product candidate, NeoCart®, leverages its platform to provide an innovative treatment in the orthopedic space, specifically cartilage damage in the knee.

Lantheus

Lantheus Holdings, Inc. is the parent company of Lantheus Medical Imaging, Inc., Progenics Pharmaceuticals, Inc. and EXINI Diagnostics AB and an established leader and fully integrated provider of innovative imaging diagnostics, targeted therapeutics and artificial intelligence solutions to Find Fight and Follow® serious medical conditions. Lantheus provides a broad portfolio of products, including the echocardiography agent DEFINITY® Vial for (Perflutren Lipid Microsphere) Injectable Suspension; TechneLite® (Technetium Tc99m Generator), a technetium-based generator that provides the essential medical isotope used in nuclear medicine procedures; AZEDRA® for the treatment of certain rare neuroendocrine tumors; and RELISTOR® for the treatment of opioid-induced constipation, which is partnered with Bausch Health Companies, Inc. The Company is headquartered in North Billerica, Massachusetts with offices in New York, New Jersey, Canada and Sweden.